Jason Auriemma, MD
Family Practice · Sacramento
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Offices
- 2
- Since medical school
- 26 years
- New York Medical College, 2000
Offices
2 locations · Sutter Valley Medical Foundation · 2,473 clinicians in this group
Hospitals listed: 557073 · Sutter Davis Hospital · Sutter Medical Center, Sacramento · Woodland Memorial Hospital. That is not proof they admit you there this week.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Auriemma’s office at (916) 454-6600 to ask if they take your plan before you enroll.
California Medical Board record
Licence A76677 · Current
Licensed to practise in California · since 2001 · expires 2027-08-31 · New York Medical College.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
School, training and certification
What this clinician told their state board, medical school and everything before it. Only some states publish this, so nothing here means the state does not say, not that there was no training or certification.
Specialty certification
- American Board of Family Medicine - Family Medicine
Hospitals they work in
3 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Sutter Davis HospitalDavis, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 4 of 5 · 82% would definitely recommend itOverall rating: 4 of 5 starsNo measure marked better or worse than the national rate
- Sutter Medical Center, SacramentoSacramento, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 3 of 5 · 79% would definitely recommend itOverall rating: 4 of 5 starsWorse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 13.9 (12 to 15.9) · 992 cases, Jan 2024 – Dec 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.066, Oct 2024 – Sep 2025Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.335, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.215, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0.46, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.253, Oct 2024 – Sep 2025
- Woodland Memorial HospitalWoodland, CAAcute Care Hospital · Voluntary non-profit - Other · Has an emergency department · Birthing-friendlyPart of CommonSpirit Health, which runs 145 hospitals in 19 statesPatients rate it 4 of 5 · 71% would definitely recommend itOverall rating: 5 of 5 starsNo measure marked better or worse than the national rate
See every measure and the patient survey for Sutter Davis Hospital
Behind the star rating — Deaths: 0 better, 5 the same, 0 worse of 5 measures. Safety: 1 better, 1 the same, 0 worse of 2 measures. Readmissions: 1 better, 7 the same, 0 worse of 8 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1 (0 to 2.07) · 247 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.88 (0.43 to 1.32) | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 9.7 · 28 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 10.6 · 151 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 14.1 · 91 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.9 · 94 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.9 · 857 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.2 (0 to 0.43) · 1,791 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.26 (0.04 to 0.47) · 1,822 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.22 (0.68 to 5.75) · 179 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.27 (0.56 to 3.98) · 161 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.73 (0.21 to 3.25) · 41 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.37 (0 to 1.4) · 1,424 cases | No different | Jul 2022 – Jun 2024 |
| Clostridium Difficile (C.Diff)Infections | 0.351 | No different | Oct 2024 – Sep 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 21 · 169 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 9.1 · 165 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -13 · 94 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.4 · 123 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 18.8 · 34 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.5 (9.6 to 16.4) · 878 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1.1 (0.8 to 1.5) · 240 cases | No different | Jan 2024 – Dec 2024 |
What patients said (406 patients answered, 18% of those asked)
| Cleanliness | 4 |
| Nurse communication | 3 |
| Doctor communication | 4 |
| Communication about medicines | 4 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 5 |
| Room was "always" clean | 82% |
| Nurses "always" communicated well | 78% |
| Doctors "always" communicated well | 83% |
| Staff "always" explained | 66% |
| Yes, staff "did" give patients this information | 90% |
| Yes, staff "did" give patients information about help after discharge | 91% |
| Doctors "always" explained things so they could understand | 78% |
| Doctors "always" listened carefully | 82% |
| Doctors "always" treated them with courtesy and respect | 89% |
| Patients who gave a rating of "9" or "10" (high) | 80% |
| Staff "always" explained new medications | 77% |
| Nurses "always" explained things so they could understand | 74% |
| Nurses "always" listened carefully | 76% |
| Nurses "always" treated them with courtesy and respect | 85% |
| "Always" quiet at night | 55% |
| "YES", patients would definitely recommend the hospital | 82% |
| Staff "always" explained possible side effects | 55% |
| Yes, staff "did" give patients information about possible symptoms | 88% |
See every measure and the patient survey for Sutter Medical Center, Sacramento
Behind the star rating — Deaths: 0 better, 8 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 0 better, 9 the same, 2 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 13.9 (12 to 15.9) · 992 cases | Worse | Jan 2024 – Dec 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.066 | Better | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.335 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.215 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.46 | Better | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.253 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.12 (0.29 to 1.94) · 2,408 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.99 (0.78 to 1.2) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 166.68 (126.66 to 206.71) · 180 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.4 · 292 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.7 · 143 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10.2 · 359 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 11.8 · 543 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 15.9 · 425 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.4 · 441 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3 · 5,216 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.11 (0 to 0.29) · 9,948 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.1 to 0.45) · 10,968 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.04 (1.53 to 4.56) · 3,983 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.33 (0.2 to 2.46) · 2,033 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.78 (1.69 to 3.87) · 3,594 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 9.79 (6.29 to 13.29) · 2,100 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 6.62 (4.04 to 9.2) · 2,018 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.63 (0.29 to 2.98) · 867 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.54 (0.07 to 1.01) · 8,613 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.3 · 294 cases | None | Apr 2023 – Mar 2025 |
| SSI - Abdominal HysterectomyInfections | 0 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15.5 · 598 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.9 · 924 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 8.5 · 488 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -18.3 · 638 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 24.4 · 443 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17.7 · 600 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 4.9 (3.9 to 6.1) · 992 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.1 · 298 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9 · 249 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.6 · 250 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 11.3 (8.7 to 14.6) · 1,326 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.8 to 1.3) · 934 cases | No different | Jan 2024 – Dec 2024 |
What patients said (700 patients answered, 20% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 3 |
| Communication about medicines | 3 |
| Discharge information | 3 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 76% |
| Nurses "always" communicated well | 80% |
| Doctors "always" communicated well | 79% |
| Staff "always" explained | 61% |
| Yes, staff "did" give patients this information | 86% |
| Yes, staff "did" give patients information about help after discharge | 84% |
| Doctors "always" explained things so they could understand | 75% |
| Doctors "always" listened carefully | 77% |
| Doctors "always" treated them with courtesy and respect | 84% |
| Patients who gave a rating of "9" or "10" (high) | 79% |
| Staff "always" explained new medications | 75% |
| Nurses "always" explained things so they could understand | 75% |
| Nurses "always" listened carefully | 78% |
| Nurses "always" treated them with courtesy and respect | 86% |
| "Always" quiet at night | 49% |
| "YES", patients would definitely recommend the hospital | 79% |
| Staff "always" explained possible side effects | 47% |
| Yes, staff "did" give patients information about possible symptoms | 87% |
See every measure and the patient survey for Woodland Memorial Hospital
Behind the star rating — Deaths: 0 better, 5 the same, 0 worse of 5 measures. Safety: 0 better, 5 the same, 0 worse of 5 measures. Readmissions: 1 better, 7 the same, 0 worse of 8 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.99 (0 to 2.04) · 255 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.03 (0.59 to 1.48) | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 8.4 · 55 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 14 · 76 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 16.8 · 102 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.3 · 85 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.8 · 699 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.19 (0 to 0.42) · 1,388 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.26 (0.05 to 0.47) · 1,448 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.13 (0.63 to 5.63) · 220 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.65 (0 to 3.38) · 86 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.23 (0.54 to 3.93) · 213 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 8.45 (0 to 18.11) · 86 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.9 (1.66 to 10.15) · 76 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 2.05 (0.54 to 3.56) · 101 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.84 (0 to 1.88) · 1,075 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4 · 26 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0 | No different | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.242 | No different | Oct 2024 – Sep 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.7 · 112 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -42.4 · 84 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 4.4 · 105 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.8 · 116 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.6 (3.7 to 8.2) · 84 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 11.6 (8.5 to 15.8) · 84 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.8 · 28 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 18.7 · 69 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 11.8 (8.9 to 15.7) · 926 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1.3 (1 to 1.8) · 227 cases | No different | Jan 2024 – Dec 2024 |
What patients said (302 patients answered, 17% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 4 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 4 |
| Room was "always" clean | 70% |
| Nurses "always" communicated well | 81% |
| Doctors "always" communicated well | 85% |
| Staff "always" explained | 66% |
| Yes, staff "did" give patients this information | 90% |
| Yes, staff "did" give patients information about help after discharge | 90% |
| Doctors "always" explained things so they could understand | 82% |
| Doctors "always" listened carefully | 84% |
| Doctors "always" treated them with courtesy and respect | 88% |
| Patients who gave a rating of "9" or "10" (high) | 72% |
| Staff "always" explained new medications | 82% |
| Nurses "always" explained things so they could understand | 76% |
| Nurses "always" listened carefully | 80% |
| Nurses "always" treated them with courtesy and respect | 87% |
| "Always" quiet at night | 43% |
| "YES", patients would definitely recommend the hospital | 71% |
| Staff "always" explained possible side effects | 51% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
Original Medicare doctor bills
$2,072
Medicare paid this office $2,072 for 27 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
Who their Medicare patients are
27 Original Medicare patients in 2024. Average age 75 · Women 59% · Health risk score 1.73. Above the middle of the specialty; the typical family practice clinician is at 1.13.
Conditions among them: High blood pressure 75% · Coronary heart disease 52% · Chronic kidney disease 52% · Heart failure 48% · Diabetes 44%.
The office billed $8,972, Medicare allowed $2,688 and paid $2,072; for 31 services of 9 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 27 | 31 | 75 | 1.73 | $8,972 | $2,072 |
| 2023 | 118 | 159 | 75 | 1.81 | $24,227 | $5,895 |
| 2022 | 127 | 254 | 75 | 1.70 | $24,291 | $6,118 |
| 2021 | 106 | 150 | 75 | 1.94 | $14,350 | $3,864 |
| 2020 | 128 | 188 | 72 | 1.63 | $17,861 | $4,990 |
| 2019 | 182 | 448 | 71 | 1.63 | $27,724 | $6,659 |
| 2018 | 145 | 521 | 67 | 1.45 | $52,481 | $3,712 |
| 2017 | 109 | 272 | 68 | 1.42 | $32,414 | $2,107 |
| 2016 | 78 | 128 | 67 | 2.96 | $40,244 | $8,960 |
| 2015 | 158 | 195 | 67 | 1.88 | $57,440 | $11,790 |
| 2014 | 17 | 19 | 64 | 2.35 | $4,331 | $1,084 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 5 services
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 18 | $1,837 | $102 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 19 | $738 | $39 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 12 | $724 | $60 |
| Hemoglobin a1c level | 32 | $419 | $10 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 11 | $128 | $12 |
2022: 6 services
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 22 | $2,232 | $101 |
| Hemoglobin a1c level | 34 | $518 | $10 |
| Follow-up observation care per day, typically 15 minutes | 14 | $448 | $32 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 13 | $235 | $18 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 13 | $157 | $12 |
| Blood count, hemoglobin | 12 | $56 | $2 |
2021: 3 services
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 12 | $1,382 | $115 |
| Hemoglobin a1c level | 34 | $466 | $10 |
| Routine electrocardiogram (ecg) using at least 12 leads with tracing | 13 | $61 | $5 |
2020: 6 services
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 17 | $1,825 | $107 |
| Hemoglobin a1c level | 45 | $596 | $10 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 15 | $486 | $32 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 14 | $225 | $16 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 14 | $150 | $11 |
| Routine electrocardiogram (ecg) using at least 12 leads with tracing | 11 | $66 | $6 |
2019: 10 services
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 17 | $1,922 | $113 |
| Hemoglobin a1c level | 83 | $1,607 | $11 |
| Blood test, clotting time | 15 | $531 | $4 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 15 | $520 | $33 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 12 | $224 | $19 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 12 | $150 | $12 |
| Routine electrocardiogram (ecg) using at least 12 leads with tracing | 24 | $138 | $6 |
| Blood count, hemoglobin | 16 | $83 | $3 |
| Blood glucose (sugar) level | 15 | $73 | $4 |
| Urinalysis, manual test | 20 | $72 | $3 |
2018: 6 services
| Hemoglobin a1c level | 96 | $2,280 | $12 |
| Blood test, clotting time | 17 | $983 | $5 |
| Routine electrocardiogram (ecg) using at least 12 leads with tracing | 25 | $152 | $6 |
| Urinalysis, manual test | 36 | $130 | $3 |
| Blood glucose (sugar) test performed by hand-held instrument | 23 | $96 | $3 |
| Blood count, hemoglobin | 19 | $72 | $3 |
2017: 5 services
| Hemoglobin a1c level | 74 | $1,292 | $13 |
| Blood test, clotting time | 18 | $539 | $5 |
| Routine electrocardiogram (ecg) using at least 12 leads with tracing | 21 | $114 | $5 |
| Blood glucose (sugar) test performed by hand-held instrument | 14 | $66 | $3 |
| Urinalysis, manual test | 13 | $48 | $3 |
2016: 2 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 16 | $2,949 | $84 |
| Return visit (30+ min) | 45 | $2,576 | $52 |
2015: 2 services
| Return visit (30+ min) | 109 | $7,276 | $61 |
| Short return visit (20+ min) | 21 | $827 | $38 |
2014: 1 service
| Return visit (30+ min) | 14 | $889 | $63 |
Medicaid work
$1,273,613 in 2024
Medicaid paid $1,273,613 for 16,895 billed services this clinician did in 2024, up to 618 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Clinic visit/encounter, all-inclusive | 5,964 | $1,251,611 |
| Short return visit (20+ min) | 3,167 | $3,810 |
| Return visit (30+ min) | 1,209 | $2,726 |
| New patient visit (30+ min) | 659 | $1,845 |
| Influenza virus vaccine, trivalent (IIV3), split virus, preservative free, 0.5 mL dosage, for intramuscular use | 336 | $1,822 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; infant (age younger than 1 year) | 227 | $1,288 |
| Annual alcohol misuse screening, 5 to 15 minutes | 393 | $1,249 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use | 153 | $1,094 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; late childhood (age 5 through 11 years) | 302 | $1,078 |
| Pneumococcal conjugate vaccine, 15 valent (PCV15), for intramuscular use | 204 | $808 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; early childhood (age 1 through 4 years) | 292 | $804 |
| Varicella virus vaccine (VAR), live, for subcutaneous use | 29 | $584 |
| 2024 | 16,895 | 41 | 618 | $1,273,613 |
| 2023 | 14,448 | 37 | 476 | $896,450 |
| 2022 | 20,721 | 42 | 459 | $933,547 |
| 2021 | 26,616 | 47 | 559 | $1,252,961 |
| 2020 | 22,594 | 37 | 537 | $1,112,358 |
| 2019 | 13,757 | 41 | 422 | $647,110 |
| 2018 | 7,747 | 20 | 513 | $805,317 |
See the largest Medicaid services in earlier years
2023
| Clinic visit/encounter, all-inclusive | 4,695 | $830,923 |
| Short return visit (20+ min) | 2,819 | $39,283 |
| Unclassified drugs | 163 | $6,483 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use | 524 | $3,797 |
| Return visit (30+ min) | 1,099 | $3,530 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; early childhood (age 1 through 4 years) | 320 | $1,874 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; infant (age younger than 1 year) | 312 | $1,639 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; late childhood (age 5 through 11 years) | 312 | $1,629 |
| Annual alcohol misuse screening, 5 to 15 minutes | 463 | $1,526 |
| Short return visit | 511 | $862 |
| Screening test, pure tone, air only | 567 | $613 |
| Preventive medicine counseling and risk factor reduction intervention for individual, approximately 15 minutes | 24 | $458 |
2022
| Clinic visit/encounter, all-inclusive | 4,542 | $753,515 |
| Other specified case management service not elsewhere classified | 880 | $69,200 |
| Short return visit (20+ min) | 5,620 | $49,173 |
| Unclassified drugs | 355 | $14,823 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use | 889 | $7,526 |
| Annual alcohol misuse screening, 5 to 15 minutes | 735 | $5,527 |
| Return visit (30+ min) | 1,172 | $4,062 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; infant (age younger than 1 year) | 386 | $3,875 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; early childhood (age 1 through 4 years) | 640 | $3,755 |
| Pneumococcal conjugate vaccine, 13 valent (PCV13), for intramuscular use | 285 | $2,696 |
| Developmental screening | 59 | $2,471 |
| Short return visit | 977 | $1,835 |
2021
| Clinic visit/encounter, all-inclusive | 6,784 | $1,112,128 |
| Short return visit (20+ min) | 7,523 | $60,898 |
| Unclassified drugs | 447 | $18,552 |
| Annual alcohol misuse screening, 5 to 15 minutes | 1,046 | $7,001 |
| Developmental screening | 125 | $4,750 |
| Return visit (30+ min) | 1,559 | $4,625 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, 0.5 mL dosage, for intramuscular use | 264 | $3,900 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; early childhood (age 1 through 4 years) | 700 | $3,828 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; infant (age younger than 1 year) | 523 | $3,609 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use | 635 | $3,468 |
| Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 30 mcg/0.3 mL dosage, diluent reconstituted; booster dose | 50 | $3,350 |
| Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 50 mcg/0.25 mL dosage, booster dose | 46 | $3,015 |
2020
| Clinic visit/encounter, all-inclusive | 6,383 | $1,013,773 |
| Short return visit (20+ min) | 6,081 | $38,877 |
| Unclassified drugs | 399 | $20,038 |
| Annual alcohol misuse screening, 5 to 15 minutes | 792 | $5,767 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, 0.5 mL dosage, for intramuscular use | 338 | $5,218 |
| Return visit (30+ min) | 1,313 | $4,349 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use | 621 | $3,868 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; early childhood (age 1 through 4 years) | 424 | $3,559 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; infant (age younger than 1 year) | 391 | $3,134 |
| Pneumococcal conjugate vaccine, 13 valent (PCV13), for intramuscular use | 326 | $2,977 |
| Tetanus, diphtheria toxoids and acellular pertussis vaccine (Tdap), when administered to individuals 7 years or older, for intramuscular use | 195 | $2,961 |
| Short return visit | 1,558 | $1,431 |
2019
| Clinic visit/encounter, all-inclusive | 3,727 | $543,335 |
| Short return visit (20+ min) | 2,658 | $45,764 |
| Unclassified drugs | 230 | $9,283 |
| Return visit (30+ min) | 1,223 | $5,585 |
| Tetanus, diphtheria toxoids and acellular pertussis vaccine (Tdap), when administered to individuals 7 years or older, for intramuscular use | 255 | $4,927 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, 0.5 mL dosage, for intramuscular use | 270 | $4,259 |
| Annual alcohol misuse screening, 5 to 15 minutes | 392 | $3,603 |
| Contraceptive pills for bc | 48 | $2,874 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use | 533 | $2,811 |
| Pneumococcal conjugate vaccine, 13 valent (PCV13), for intramuscular use | 252 | $2,673 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; infant (age younger than 1 year) | 241 | $2,518 |
| Medical nutrition therapy; initial assessment and intervention, individual, face-to-face with the patient, each 15 minutes | 27 | $2,428 |
2018
| Clinic visit/encounter, all-inclusive | 5,357 | $742,618 |
| Short return visit (20+ min) | 542 | $39,299 |
| OFFICE/OUTPATIENT NEW SF MDM 15 MINUTES | 37 | $7,688 |
| Unclassified drugs | 165 | $6,049 |
| Return visit (30+ min) | 710 | $3,591 |
| Preventive medicine counseling and risk factor reduction intervention for individual, approximately 30 minutes | 55 | $1,748 |
| Contraceptive pills for bc | 33 | $1,151 |
| Contraceptive supply, condom, male, each | 187 | $864 |
| Patient education, not otherwise classified, non-physician provider, individual, per session | 55 | $700 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use | 59 | $531 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, 0.5 mL dosage, for intramuscular use | 16 | $357 |
| Preventive medicine counseling and risk factor reduction intervention for individual, approximately 15 minutes | 15 | $286 |
Drugs they prescribed that Part D paid
$446,209
Pharmacies billed $446,209 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 4% of their Part D prescriptions (131 of 3,381) in 2024. Above the middle of the specialty; the typical family practice clinician is at 2%. Long-acting opioids: 10% of their opioid prescriptions.
2,839 generic and 510 brand-name prescriptions · $446,209 in drug cost · 51 antibiotic prescriptions to 20 people · 29 antipsychotic prescriptions to people over 65.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Jardiance | 63 | $75,249 | $1,194 |
| Xifaxan | 19 | $67,479 | $3,552 |
| Trulicity | 43 | $52,017 | $1,210 |
| Januvia | 34 | $45,977 | $1,352 |
| Eliquis | 82 | $40,791 | $497 |
See all 65 drugs
| Jardiance | 63 | $75,249 | $1,194 |
| Xifaxan | 19 | $67,479 | $3,552 |
| Trulicity | 43 | $52,017 | $1,210 |
| Januvia | 34 | $45,977 | $1,352 |
| Eliquis | 82 | $40,791 | $497 |
| Ozempic | 18 | $18,507 | $1,028 |
| Basaglar Kwikpen U-100 | 34 | $14,604 | $430 |
| Trelegy Ellipta | 12 | $10,502 | $875 |
| Combivent Respimat | 14 | $8,004 | $572 |
| Lantus Solostar | 22 | $3,384 | $154 |
| Gabapentin | 115 | $2,971 | $26 |
| Hydrocodone-Acetaminophen | 86 | $2,701 | $31 |
| Albuterol Sulfate Hfa | 35 | $1,728 | $49 |
| Lactulose | 14 | $1,640 | $117 |
| Atorvastatin | 291 | $1,588 | $5 |
| Omeprazole | 130 | $1,454 | $11 |
| Fentanyl | 11 | $1,239 | $113 |
| Lisinopril | 202 | $1,109 | $5 |
| Metformin | 142 | $879 | $6 |
| Metoprolol | 50 | $791 | $16 |
| Tamsulosin | 53 | $760 | $14 |
| Pantoprazole | 99 | $544 | $5 |
| Fluticasone Propionate | 34 | $542 | $16 |
| Losartan | 86 | $506 | $6 |
| Pioglitazone | 47 | $483 | $10 |
| Finasteride | 41 | $478 | $12 |
| Amlodipine Besylate | 90 | $461 | $5 |
| Constulose | 14 | $396 | $28 |
| Levothyroxine | 41 | $376 | $9 |
| Clopidogrel | 17 | $332 | $20 |
| Ipratropium | 12 | $311 | $26 |
| Doxazosin Mesylate | 29 | $280 | $10 |
| Furosemide | 69 | $274 | $4 |
| Carvedilol | 44 | $258 | $6 |
| Ibuprofen | 44 | $237 | $5 |
| Hydrochlorothiazide | 90 | $228 | $3 |
| Hydroxyzine | 26 | $221 | $9 |
| Simvastatin | 48 | $207 | $4 |
| Rosuvastatin | 22 | $205 | $9 |
| Allopurinol | 26 | $203 | $8 |
| Famotidine | 15 | $201 | $13 |
| Amitriptyline | 33 | $182 | $6 |
| Paroxetine | 12 | $169 | $14 |
| Baclofen | 18 | $155 | $9 |
| Metoprolol | 26 | $153 | $6 |
| Sertraline | 38 | $146 | $4 |
| Triamcinolone Acetonide | 19 | $130 | $7 |
| Trazodone | 18 | $120 | $7 |
| Tizanidine | 16 | $118 | $7 |
| Spironolactone | 11 | $113 | $10 |
| Quetiapine | 14 | $102 | $7 |
| Citalopram Hbr | 28 | $102 | $4 |
| Fluoxetine | 16 | $92 | $6 |
| Ropinirole | 12 | $87 | $7 |
| Glipizide | 13 | $77 | $6 |
| Alendronate | 22 | $62 | $3 |
| Naproxen | 14 | $57 | $4 |
| Tramadol | 22 | $56 | $3 |
| Meloxicam | 30 | $56 | $2 |
| Lisinopril-Hydrochlorothiazide | 15 | $47 | $3 |
| Prednisone | 13 | $46 | $4 |
| Glimepiride | 14 | $45 | $3 |
| Risperidone | 11 | $44 | $4 |
| Lovastatin | 13 | $39 | $3 |
| Warfarin | 16 | $28 | $2 |
Year by year
| 2024 | 3,381 | 185 | 4% (131) | 15% | $446,209 |
| 2023 | 3,237 | 188 | 4% (139) | 14% | $428,067 |
| 2022 | 3,007 | 163 | 4% (105) | 15% | $434,909 |
| 2021 | 2,992 | 168 | 4% (117) | 13% | $359,603 |
| 2020 | 3,126 | 174 | 5% (165) | 11% | $264,956 |
| 2019 | 3,559 | 186 | 5% (172) | 15% | $315,927 |
| 2018 | 3,357 | 184 | 5% (180) | 15% | $255,010 |
| 2017 | 3,263 | 174 | 6% (181) | 14% | $196,831 |
| 2016 | 3,609 | 178 | 6% (231) | 15% | $224,910 |
| 2015 | 3,500 | 163 | 7% (239) | 16% | $204,277 |
| 2014 | 3,551 | 154 | 6% (222) | 17% | $215,188 |
| 2013 | 4,203 | 170 | 6% (267) | 16% | $236,503 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 62 drugs
| Jardiance | 34 | $50,424 | $1,483 |
| Januvia | 31 | $49,804 | $1,607 |
| Trulicity | 31 | $38,857 | $1,253 |
| Xarelto | 20 | $28,252 | $1,413 |
| Basaglar Kwikpen U-100 | 55 | $26,742 | $486 |
| Eliquis | 33 | $17,657 | $535 |
| Spiriva Respimat | 16 | $13,008 | $813 |
| Combivent Respimat | 12 | $9,335 | $778 |
| Incruse Ellipta | 14 | $9,249 | $661 |
| Lantus Solostar | 11 | $7,157 | $651 |
| Atorvastatin | 284 | $6,808 | $24 |
| Gabapentin | 118 | $5,027 | $43 |
| Omeprazole | 142 | $3,696 | $26 |
| Lisinopril | 226 | $3,275 | $14 |
| Hydrocodone-Acetaminophen | 96 | $2,578 | $27 |
| Metformin | 131 | $2,086 | $16 |
| Losartan | 87 | $1,831 | $21 |
| Colchicine | 14 | $1,807 | $129 |
| Amlodipine Besylate | 87 | $1,794 | $21 |
| Tamsulosin | 39 | $1,746 | $45 |
| Ventolin Hfa | 16 | $1,725 | $108 |
| Lactulose | 17 | $1,635 | $96 |
| Albuterol Sulfate Hfa | 30 | $1,581 | $53 |
| Quetiapine | 16 | $1,537 | $96 |
| Pioglitazone | 43 | $1,351 | $31 |
| Pantoprazole | 83 | $1,236 | $15 |
| Metoprolol | 39 | $1,230 | $32 |
| Finasteride | 45 | $1,201 | $27 |
| Doxazosin Mesylate | 40 | $1,061 | $27 |
| Fentanyl | 11 | $1,008 | $92 |
| Furosemide | 80 | $963 | $12 |
| Metoprolol | 32 | $823 | $26 |
| Sertraline | 28 | $820 | $29 |
| Levothyroxine | 44 | $802 | $18 |
| Allopurinol | 30 | $793 | $26 |
| Carvedilol | 33 | $793 | $24 |
| Simvastatin | 56 | $741 | $13 |
| Baclofen | 30 | $600 | $20 |
| Ibuprofen | 32 | $581 | $18 |
| Hydrochlorothiazide | 98 | $558 | $6 |
| Meloxicam | 25 | $556 | $22 |
| Olmesartan Medoxomil | 11 | $555 | $50 |
| Duloxetine | 20 | $551 | $28 |
| Fluticasone Propionate | 29 | $511 | $18 |
| Mirtazapine | 18 | $498 | $28 |
| Morphine Sulfate | 11 | $476 | $43 |
| Clopidogrel | 19 | $434 | $23 |
| Digoxin | 11 | $423 | $38 |
| Amitriptyline | 28 | $348 | $12 |
| Famotidine | 12 | $334 | $28 |
| Citalopram Hbr | 26 | $314 | $12 |
| Lisinopril-Hydrochlorothiazide | 12 | $270 | $23 |
| Cyclobenzaprine | 12 | $269 | $22 |
| Lovastatin | 18 | $266 | $15 |
| Tizanidine | 14 | $266 | $19 |
| Tramadol | 19 | $255 | $13 |
| Naproxen | 22 | $228 | $10 |
| Trazodone | 15 | $119 | $8 |
| Risperidone | 13 | $93 | $7 |
| Levetiracetam | 13 | $81 | $6 |
| Prednisone | 11 | $77 | $7 |
| Spironolactone | 12 | $64 | $5 |
2022: 64 drugs
| Jardiance | 37 | $57,771 | $1,561 |
| Januvia | 40 | $54,286 | $1,357 |
| Trulicity | 32 | $36,302 | $1,134 |
| Lantus Solostar | 30 | $24,593 | $820 |
| Xarelto | 17 | $19,970 | $1,175 |
| Eliquis | 22 | $16,649 | $757 |
| Spiriva Respimat | 16 | $12,572 | $786 |
| Basaglar Kwikpen U-100 | 18 | $11,778 | $654 |
| Symbicort | 13 | $8,513 | $655 |
| Novolog Flexpen | 16 | $7,671 | $479 |
| Incruse Ellipta | 12 | $6,910 | $576 |
| Admelog | 14 | $6,690 | $478 |
| Linzess | 12 | $6,399 | $533 |
| Gabapentin | 122 | $5,533 | $45 |
| Atorvastatin | 259 | $3,198 | $12 |
| Omeprazole | 160 | $2,561 | $16 |
| Hydrocodone-Acetaminophen | 73 | $1,998 | $27 |
| Lisinopril | 202 | $1,963 | $10 |
| Ventolin Hfa | 23 | $1,772 | $77 |
| Albuterol Sulfate Hfa | 28 | $1,726 | $62 |
| Metformin | 105 | $1,301 | $12 |
| Metoprolol | 48 | $1,213 | $25 |
| Amlodipine Besylate | 98 | $1,207 | $12 |
| Quetiapine | 19 | $1,098 | $58 |
| Tamsulosin | 39 | $1,026 | $26 |
| Lactulose | 13 | $955 | $73 |
| Finasteride | 50 | $942 | $19 |
| Doxazosin Mesylate | 35 | $794 | $23 |
| Losartan | 73 | $784 | $11 |
| Simvastatin | 51 | $635 | $12 |
| Carvedilol | 35 | $622 | $18 |
| Ibuprofen | 38 | $601 | $16 |
| Fluticasone Propionate | 35 | $587 | $17 |
| Baclofen | 27 | $574 | $21 |
| Allopurinol | 24 | $559 | $23 |
| Levothyroxine | 38 | $555 | $15 |
| Pioglitazone | 28 | $533 | $19 |
| Sertraline | 38 | $498 | $13 |
| Hydrochlorothiazide | 83 | $487 | $6 |
| Furosemide | 70 | $445 | $6 |
| Insulin | 11 | $404 | $37 |
| Metoprolol | 40 | $396 | $10 |
| Temazepam | 20 | $390 | $19 |
| Pantoprazole | 37 | $370 | $10 |
| Digoxin | 17 | $321 | $19 |
| Mirtazapine | 13 | $307 | $24 |
| Lovastatin | 18 | $278 | $15 |
| Potassium Chloride | 11 | $274 | $25 |
| Benazepril | 13 | $267 | $21 |
| Citalopram Hbr | 43 | $264 | $6 |
| Amitriptyline | 18 | $217 | $12 |
| Tramadol | 20 | $208 | $10 |
| Clopidogrel | 16 | $190 | $12 |
| Glimepiride | 11 | $185 | $17 |
| Triamcinolone Acetonide | 17 | $154 | $9 |
| Meloxicam | 29 | $141 | $5 |
| Clonidine | 13 | $139 | $11 |
| Naproxen | 18 | $116 | $6 |
| Alendronate | 14 | $116 | $8 |
| Prednisone | 12 | $108 | $9 |
| Hydroxyzine | 14 | $95 | $7 |
| Risperidone | 13 | $94 | $7 |
| Ropinirole | 15 | $86 | $6 |
| Famotidine | 12 | $29 | $2 |
2021: 60 drugs
| Januvia | 35 | $51,558 | $1,473 |
| Xifaxan | 12 | $31,855 | $2,655 |
| Trulicity | 13 | $28,382 | $2,183 |
| Lantus Solostar | 37 | $27,763 | $750 |
| Xarelto | 18 | $23,152 | $1,286 |
| Basaglar Kwikpen U-100 | 23 | $17,584 | $765 |
| Jardiance | 13 | $12,176 | $937 |
| Spiriva Respimat | 11 | $11,158 | $1,014 |
| Linzess | 12 | $6,519 | $543 |
| Flovent Hfa | 14 | $5,063 | $362 |
| Novolog | 12 | $4,563 | $380 |
| Gabapentin | 132 | $4,242 | $32 |
| Atorvastatin | 222 | $4,145 | $19 |
| Omeprazole | 184 | $3,367 | $18 |
| Ventolin Hfa | 21 | $2,373 | $113 |
| Lisinopril | 213 | $2,198 | $10 |
| Hydrocodone-Acetaminophen | 82 | $2,053 | $25 |
| Albuterol Sulfate Hfa | 24 | $1,602 | $67 |
| Metformin | 109 | $1,206 | $11 |
| Metoprolol | 42 | $1,186 | $28 |
| Pregabalin | 11 | $1,173 | $107 |
| Finasteride | 43 | $1,114 | $26 |
| Levetiracetam | 12 | $1,029 | $86 |
| Losartan | 60 | $943 | $16 |
| Fluticasone Propionate | 57 | $939 | $16 |
| Baclofen | 38 | $850 | $22 |
| Amlodipine Besylate | 91 | $838 | $9 |
| Tamsulosin | 36 | $831 | $23 |
| Ibuprofen | 57 | $750 | $13 |
| Simvastatin | 62 | $737 | $12 |
| Hydroxyzine | 30 | $713 | $24 |
| Hydrochlorothiazide | 89 | $711 | $8 |
| Doxazosin Mesylate | 27 | $693 | $26 |
| Sertraline | 52 | $656 | $13 |
| Allopurinol | 31 | $629 | $20 |
| Levothyroxine | 32 | $562 | $18 |
| Ipratropium | 11 | $551 | $50 |
| Diclofenac | 23 | $530 | $23 |
| Carvedilol | 40 | $529 | $13 |
| Pioglitazone | 23 | $477 | $21 |
| Cyclobenzaprine | 11 | $445 | $40 |
| Citalopram Hbr | 43 | $439 | $10 |
| Pantoprazole | 35 | $395 | $11 |
| Metoprolol | 46 | $360 | $8 |
| Furosemide | 46 | $346 | $8 |
| Amitriptyline | 18 | $302 | $17 |
| Glimepiride | 24 | $296 | $12 |
| Lovastatin | 17 | $266 | $16 |
| Temazepam | 23 | $259 | $11 |
| Famotidine | 24 | $228 | $10 |
| Clopidogrel | 12 | $215 | $18 |
| Tramadol | 14 | $186 | $13 |
| Meloxicam | 24 | $152 | $6 |
| Warfarin | 12 | $143 | $12 |
| Benazepril | 15 | $141 | $9 |
| Naproxen | 15 | $117 | $8 |
| Montelukast | 12 | $116 | $10 |
| Meclizine | 20 | $106 | $5 |
| Triamcinolone Acetonide | 16 | $105 | $7 |
| Glipizide | 15 | $35 | $2 |
2020: 59 drugs
| Januvia | 45 | $52,262 | $1,161 |
| Xarelto | 27 | $26,213 | $971 |
| Basaglar Kwikpen U-100 | 34 | $16,094 | $473 |
| Oxycontin | 13 | $14,239 | $1,095 |
| Lantus Solostar | 20 | $13,639 | $682 |
| Spiriva Respimat | 15 | $13,145 | $876 |
| Combivent Respimat | 11 | $10,212 | $928 |
| Flovent Hfa | 21 | $9,906 | $472 |
| Linzess | 13 | $6,116 | $470 |
| Atorvastatin | 221 | $3,377 | $15 |
| Gabapentin | 132 | $2,860 | $22 |
| Omeprazole | 172 | $2,759 | $16 |
| Hydrocodone-Acetaminophen | 116 | $2,670 | $23 |
| Lisinopril | 194 | $1,608 | $8 |
| Metoprolol | 50 | $1,391 | $28 |
| Ventolin Hfa | 22 | $1,268 | $58 |
| Albuterol Sulfate Hfa | 21 | $1,240 | $59 |
| Hydroxyzine | 56 | $1,044 | $19 |
| Fluticasone Propionate | 62 | $954 | $15 |
| Metformin | 125 | $949 | $8 |
| Levothyroxine | 31 | $892 | $29 |
| Finasteride | 47 | $811 | $17 |
| Losartan | 65 | $798 | $12 |
| Ibuprofen | 105 | $715 | $7 |
| Diclofenac | 42 | $691 | $16 |
| Hydrochlorothiazide | 102 | $639 | $6 |
| Baclofen | 28 | $633 | $23 |
| Amitriptyline | 33 | $627 | $19 |
| Doxazosin Mesylate | 20 | $577 | $29 |
| Ultra-Fine Mini Pen Needle | 12 | $573 | $48 |
| Carvedilol | 45 | $511 | $11 |
| Amlodipine Besylate | 94 | $504 | $5 |
| Simvastatin | 58 | $480 | $8 |
| Allopurinol | 32 | $463 | $14 |
| Metoprolol | 67 | $446 | $7 |
| Pioglitazone | 36 | $440 | $12 |
| Lovastatin | 26 | $399 | $15 |
| Tamsulosin | 29 | $374 | $13 |
| Clopidogrel | 15 | $366 | $24 |
| Glimepiride | 47 | $350 | $7 |
| Sertraline | 25 | $308 | $12 |
| Furosemide | 44 | $270 | $6 |
| Pantoprazole | 28 | $260 | $9 |
| Tramadol | 23 | $252 | $11 |
| Citalopram Hbr | 43 | $244 | $6 |
| Levetiracetam | 12 | $209 | $17 |
| Naproxen | 21 | $208 | $10 |
| Lisinopril-Hydrochlorothiazide | 35 | $207 | $6 |
| Warfarin | 13 | $174 | $13 |
| Benazepril | 11 | $146 | $13 |
| Zolpidem | 11 | $143 | $13 |
| Cyclobenzaprine | 11 | $107 | $10 |
| Triamcinolone Acetonide | 15 | $88 | $6 |
| Meloxicam | 15 | $80 | $5 |
| Metformin Hcl Er | 13 | $80 | $6 |
| Montelukast | 15 | $61 | $4 |
| Metoclopramide | 13 | $60 | $5 |
| Atenolol | 16 | $55 | $3 |
| Prednisone | 13 | $48 | $4 |
2019: 72 drugs
| Januvia | 39 | $40,968 | $1,050 |
| Lantus Solostar | 35 | $28,944 | $827 |
| Xarelto | 31 | $22,019 | $710 |
| Basaglar Kwikpen U-100 | 39 | $19,472 | $499 |
| Anoro Ellipta | 15 | $14,066 | $938 |
| Oxycontin | 11 | $12,142 | $1,104 |
| Flovent Hfa | 24 | $9,901 | $413 |
| Novolog Flexpen | 13 | $7,405 | $570 |
| Humalog Kwikpen U-100 | 12 | $6,809 | $567 |
| Symbicort | 16 | $5,817 | $364 |
| Linzess | 12 | $5,200 | $433 |
| Incruse Ellipta | 14 | $5,089 | $364 |
| Atorvastatin | 257 | $4,137 | $16 |
| Hydrocodone-Acetaminophen | 136 | $3,648 | $27 |
| Flovent Diskus | 12 | $3,455 | $288 |
| Ventolin Hfa | 43 | $3,454 | $80 |
| Gabapentin | 115 | $2,334 | $20 |
| Omeprazole | 179 | $2,202 | $12 |
| Lisinopril | 225 | $1,775 | $8 |
| Estradiol | 11 | $1,405 | $128 |
| Metoprolol | 55 | $1,306 | $24 |
| Finasteride | 49 | $1,057 | $22 |
| Metformin | 125 | $974 | $8 |
| Doxazosin Mesylate | 34 | $904 | $27 |
| Hydrochlorothiazide | 132 | $858 | $6 |
| Levothyroxine | 37 | $813 | $22 |
| Baclofen | 58 | $799 | $14 |
| Albuterol Sulfate Hfa | 13 | $789 | $61 |
| Fluticasone Propionate | 59 | $745 | $13 |
| Hydroxyzine | 40 | $712 | $18 |
| Ultra-Fine Mini Pen Needle | 16 | $703 | $44 |
| Potassium Chloride | 11 | $607 | $55 |
| Pioglitazone | 20 | $573 | $29 |
| Simvastatin | 71 | $571 | $8 |
| Amlodipine Besylate | 114 | $568 | $5 |
| Losartan | 64 | $562 | $9 |
| Amitriptyline | 41 | $545 | $13 |
| Carvedilol | 44 | $472 | $11 |
| Glimepiride | 64 | $471 | $7 |
| Tamsulosin | 23 | $467 | $20 |
| Allopurinol | 30 | $466 | $16 |
| Ibuprofen | 70 | $415 | $6 |
| Cyclobenzaprine | 13 | $387 | $30 |
| Diclofenac | 15 | $382 | $25 |
| Ranitidine | 22 | $374 | $17 |
| Lovastatin | 35 | $369 | $11 |
| Metoprolol | 69 | $353 | $5 |
| Pantoprazole | 26 | $346 | $13 |
| Clopidogrel | 16 | $316 | $20 |
| Furosemide | 44 | $311 | $7 |
| Temazepam | 14 | $292 | $21 |
| Sertraline | 33 | $290 | $9 |
| Ipratropium | 14 | $286 | $20 |
| Warfarin | 25 | $264 | $11 |
| Montelukast | 26 | $258 | $10 |
| Pravastatin | 11 | $256 | $23 |
| Mirtazapine | 11 | $235 | $21 |
| Citalopram Hbr | 41 | $235 | $6 |
| Lisinopril-Hydrochlorothiazide | 39 | $220 | $6 |
| Levetiracetam | 21 | $195 | $9 |
| Fluoxetine | 13 | $184 | $14 |
| Terazosin | 18 | $177 | $10 |
| Triamcinolone Acetonide | 12 | $157 | $13 |
| Glipizide Er | 11 | $147 | $13 |
| Naproxen | 16 | $138 | $9 |
| Benazepril | 12 | $130 | $11 |
| Tramadol | 20 | $129 | $6 |
| Trazodone | 12 | $123 | $10 |
| Lactulose | 14 | $98 | $7 |
| Clonidine | 18 | $95 | $5 |
| Meloxicam | 22 | $84 | $4 |
| Prednisone | 14 | $38 | $3 |
2018: 68 drugs
| Lantus Solostar | 34 | $26,867 | $790 |
| Januvia | 16 | $20,025 | $1,252 |
| Basaglar Kwikpen U-100 | 29 | $14,031 | $484 |
| Oxycontin | 12 | $12,133 | $1,011 |
| Flovent Hfa | 29 | $11,213 | $387 |
| Anoro Ellipta | 11 | $10,472 | $952 |
| Incruse Ellipta | 14 | $6,581 | $470 |
| Lyrica | 13 | $6,226 | $479 |
| Spiriva | 13 | $5,945 | $457 |
| Chantix | 14 | $5,827 | $416 |
| Linzess | 12 | $4,750 | $396 |
| Ventolin Hfa | 53 | $4,452 | $84 |
| Combivent Respimat | 11 | $4,182 | $380 |
| Aripiprazole | 14 | $4,027 | $288 |
| Clonidine | 15 | $3,860 | $257 |
| Atorvastatin | 211 | $3,387 | $16 |
| Hydrocodone-Acetaminophen | 129 | $3,182 | $25 |
| Omeprazole | 202 | $1,653 | $8 |
| Metoprolol | 49 | $1,406 | $29 |
| Gabapentin | 106 | $1,330 | $13 |
| Lisinopril | 168 | $1,147 | $7 |
| Metformin | 150 | $1,008 | $7 |
| Levothyroxine | 37 | $889 | $24 |
| Potassium Chloride | 14 | $878 | $63 |
| Doxazosin Mesylate | 29 | $874 | $30 |
| Warfarin | 75 | $834 | $11 |
| Hydrochlorothiazide | 156 | $830 | $5 |
| Cyclobenzaprine | 26 | $793 | $30 |
| Hydroxyzine | 30 | $761 | $25 |
| Ultra-Fine Short Pen Needle | 13 | $577 | $44 |
| Glimepiride | 53 | $573 | $11 |
| Amlodipine Besylate | 106 | $555 | $5 |
| Fluticasone Propionate | 54 | $511 | $9 |
| Pioglitazone | 23 | $448 | $19 |
| Simvastatin | 62 | $448 | $7 |
| Tamsulosin | 21 | $428 | $20 |
| Losartan | 56 | $424 | $8 |
| Ibuprofen | 52 | $403 | $8 |
| Furosemide | 84 | $377 | $4 |
| Amitriptyline | 21 | $361 | $17 |
| Bupropion Hcl Sr | 16 | $351 | $22 |
| Finasteride | 25 | $344 | $14 |
| Carvedilol | 41 | $323 | $8 |
| Lovastatin | 29 | $300 | $10 |
| Insulin | 11 | $295 | $27 |
| Metoprolol | 56 | $292 | $5 |
| Polyethylene Glycol 3350 | 14 | $253 | $18 |
| Clopidogrel | 20 | $229 | $11 |
| Baclofen | 24 | $225 | $9 |
| Levetiracetam | 25 | $221 | $9 |
| Naproxen | 19 | $220 | $12 |
| Sertraline | 23 | $218 | $9 |
| Allopurinol | 11 | $212 | $19 |
| Citalopram Hbr | 43 | $207 | $5 |
| Pantoprazole | 22 | $204 | $9 |
| Oxycodone-Acetaminophen | 13 | $189 | $15 |
| Topiramate | 16 | $188 | $12 |
| Lisinopril-Hydrochlorothiazide | 39 | $166 | $4 |
| Ranitidine | 18 | $165 | $9 |
| Rizatriptan | 12 | $153 | $13 |
| Montelukast | 20 | $139 | $7 |
| Tramadol | 22 | $130 | $6 |
| Benazepril | 12 | $110 | $9 |
| Triamcinolone Acetonide | 25 | $103 | $4 |
| Alendronate | 14 | $95 | $7 |
| Ibu | 12 | $83 | $7 |
| Fluconazole | 14 | $62 | $4 |
| Trazodone | 13 | $56 | $4 |
2017: 70 drugs
| Lantus Solostar | 45 | $23,172 | $515 |
| Januvia | 14 | $12,321 | $880 |
| Lantus | 28 | $12,147 | $434 |
| Oxycontin | 12 | $11,142 | $928 |
| Combivent Respimat | 15 | $6,999 | $467 |
| Advair Diskus | 12 | $6,670 | $556 |
| Flovent Hfa | 15 | $6,115 | $408 |
| Lyrica | 14 | $6,099 | $436 |
| Namenda Xr | 12 | $4,624 | $385 |
| Linzess | 13 | $4,602 | $354 |
| Atorvastatin | 205 | $3,515 | $17 |
| Ventolin Hfa | 24 | $2,475 | $103 |
| Hydrocodone-Acetaminophen | 113 | $1,480 | $13 |
| Gabapentin | 92 | $1,331 | $14 |
| Metoprolol | 63 | $1,270 | $20 |
| Omeprazole | 171 | $1,239 | $7 |
| Metformin | 173 | $1,106 | $6 |
| Levothyroxine | 46 | $1,099 | $24 |
| Warfarin | 69 | $1,096 | $16 |
| Lisinopril | 153 | $1,094 | $7 |
| Doxazosin Mesylate | 34 | $993 | $29 |
| Hydrochlorothiazide | 169 | $811 | $5 |
| Rosuvastatin | 15 | $712 | $47 |
| Glimepiride | 39 | $677 | $17 |
| Fluticasone Propionate | 50 | $534 | $11 |
| Simvastatin | 72 | $531 | $7 |
| Amlodipine Besylate | 103 | $522 | $5 |
| Hydroxyzine | 11 | $491 | $45 |
| Tamsulosin | 13 | $468 | $36 |
| Allopurinol | 22 | $444 | $20 |
| Pioglitazone | 23 | $437 | $19 |
| Amitriptyline | 30 | $425 | $14 |
| Losartan | 46 | $388 | $8 |
| Temazepam | 18 | $364 | $20 |
| Bupropion Hcl Sr | 14 | $350 | $25 |
| Lovastatin | 32 | $343 | $11 |
| Furosemide | 78 | $326 | $4 |
| Insulin | 12 | $321 | $27 |
| Citalopram Hbr | 74 | $310 | $4 |
| Sertraline | 37 | $295 | $8 |
| Clopidogrel | 27 | $293 | $11 |
| Pravastatin | 11 | $290 | $26 |
| Metoprolol | 57 | $281 | $5 |
| Carvedilol | 38 | $276 | $7 |
| Polyethylene Glycol 3350 | 20 | $264 | $13 |
| Fluoxetine | 14 | $251 | $18 |
| Ranitidine | 25 | $248 | $10 |
| Baclofen | 19 | $244 | $13 |
| Finasteride | 13 | $235 | $18 |
| Alendronate | 26 | $228 | $9 |
| Oxycodone-Acetaminophen | 13 | $204 | $16 |
| Lisinopril-Hydrochlorothiazide | 25 | $195 | $8 |
| Levetiracetam | 18 | $191 | $11 |
| Pantoprazole | 27 | $180 | $7 |
| Naproxen | 21 | $176 | $8 |
| Lactulose | 16 | $147 | $9 |
| Donepezil | 17 | $141 | $8 |
| Jantoven | 11 | $133 | $12 |
| Ibu | 20 | $130 | $6 |
| Acetaminophen-Codeine | 14 | $127 | $9 |
| Clonidine | 17 | $123 | $7 |
| Ibuprofen | 28 | $117 | $4 |
| Dicyclomine | 12 | $112 | $9 |
| Terbinafine | 17 | $111 | $7 |
| Triamterene-Hydrochlorothiazid | 12 | $104 | $9 |
| Benazepril | 12 | $85 | $7 |
| Trazodone | 18 | $71 | $4 |
| Tramadol | 20 | $49 | $2 |
| Meclizine | 11 | $43 | $4 |
| Cyclobenzaprine | 20 | $39 | $2 |
2016: 75 drugs
| Lantus Solostar | 52 | $25,649 | $493 |
| Spiriva | 23 | $15,165 | $659 |
| Januvia | 26 | $13,908 | $535 |
| Oxycontin | 12 | $10,288 | $857 |
| Advair Diskus | 14 | $10,229 | $731 |
| Flovent Hfa | 27 | $9,311 | $345 |
| Pradaxa | 16 | $7,575 | $473 |
| Lantus | 22 | $7,539 | $343 |
| Lyrica | 16 | $7,496 | $469 |
| Combivent Respimat | 15 | $7,354 | $490 |
| Vesicare | 11 | $4,874 | $443 |
| Hydrocodone-Acetaminophen | 137 | $4,678 | $34 |
| Atorvastatin | 179 | $3,755 | $21 |
| Symbicort | 11 | $3,686 | $335 |
| Gabapentin | 105 | $2,148 | $20 |
| Ventolin Hfa | 19 | $1,745 | $92 |
| Metoprolol | 49 | $1,665 | $34 |
| Fenofibrate | 29 | $1,576 | $54 |
| Omeprazole | 214 | $1,568 | $7 |
| Proair Hfa | 15 | $1,459 | $97 |
| Levothyroxine | 61 | $1,439 | $24 |
| Lisinopril | 166 | $1,299 | $8 |
| Metformin | 198 | $1,201 | $6 |
| Bd Ultra-Fine Pen Needle | 33 | $1,167 | $35 |
| Doxazosin Mesylate | 44 | $1,074 | $24 |
| Warfarin | 79 | $1,064 | $13 |
| Hydrochlorothiazide | 204 | $874 | $4 |
| Glimepiride | 63 | $850 | $13 |
| Fenofibrate | 14 | $822 | $59 |
| Allopurinol | 42 | $702 | $17 |
| Amitriptyline | 38 | $667 | $18 |
| Primidone | 12 | $661 | $55 |
| Fluticasone Propionate | 56 | $611 | $11 |
| Simvastatin | 87 | $610 | $7 |
| Losartan | 59 | $543 | $9 |
| Ranitidine | 34 | $538 | $16 |
| Acetaminophen-Codeine | 28 | $506 | $18 |
| Finasteride | 24 | $499 | $21 |
| Pioglitazone | 28 | $456 | $16 |
| Lovastatin | 49 | $403 | $8 |
| Fluoxetine | 28 | $400 | $14 |
| Amlodipine Besylate | 73 | $399 | $5 |
| Baclofen | 28 | $385 | $14 |
| Bupropion Hcl Sr | 14 | $363 | $26 |
| Citalopram Hbr | 56 | $337 | $6 |
| Lactulose | 25 | $318 | $13 |
| Polyethylene Glycol 3350 | 18 | $310 | $17 |
| Tamsulosin | 16 | $309 | $19 |
| Metoprolol | 62 | $298 | $5 |
| Clopidogrel | 26 | $294 | $11 |
| Carvedilol | 40 | $293 | $7 |
| Ibuprofen | 35 | $278 | $8 |
| Sertraline | 32 | $275 | $9 |
| Lisinopril-Hydrochlorothiazide | 32 | $257 | $8 |
| Alendronate | 33 | $252 | $8 |
| Spironolactone | 20 | $247 | $12 |
| Furosemide | 66 | $243 | $4 |
| Enalapril Maleate | 12 | $231 | $19 |
| Oxycodone-Acetaminophen | 17 | $224 | $13 |
| Jantoven | 17 | $194 | $11 |
| Triamterene-Hydrochlorothiazid | 19 | $189 | $10 |
| Temazepam | 14 | $189 | $13 |
| Insulin | 13 | $181 | $14 |
| Naproxen | 18 | $177 | $10 |
| Benazepril | 24 | $176 | $7 |
| Mirtazapine | 11 | $132 | $12 |
| Glipizide | 12 | $105 | $9 |
| Clonidine | 18 | $103 | $6 |
| Terbinafine | 14 | $99 | $7 |
| Trazodone | 14 | $91 | $7 |
| Lorazepam | 13 | $73 | $6 |
| Dicyclomine | 12 | $69 | $6 |
| Metoclopramide | 12 | $62 | $5 |
| Cyclobenzaprine | 12 | $43 | $4 |
| Tramadol | 18 | $31 | $2 |
2015: 67 drugs
| Spiriva | 27 | $18,538 | $687 |
| Lantus Solostar | 45 | $17,207 | $382 |
| Advair Diskus | 13 | $10,931 | $841 |
| Oxycontin | 12 | $8,122 | $677 |
| Flovent Hfa | 27 | $6,664 | $247 |
| Januvia | 14 | $6,408 | $458 |
| Hydrocodone-Acetaminophen | 139 | $6,325 | $46 |
| Azilect | 11 | $5,899 | $536 |
| Combivent Respimat | 14 | $5,594 | $400 |
| Crestor | 19 | $5,296 | $279 |
| Apidra Solostar | 11 | $5,001 | $455 |
| Tolterodine Tartrate Er | 12 | $4,676 | $390 |
| Atorvastatin | 194 | $4,193 | $22 |
| Enablex | 11 | $4,035 | $367 |
| Benicar | 11 | $3,638 | $331 |
| Omeprazole | 209 | $2,249 | $11 |
| Proair Hfa | 25 | $2,158 | $86 |
| Fenofibrate | 34 | $1,990 | $59 |
| Doxazosin Mesylate | 58 | $1,867 | $32 |
| Gabapentin | 85 | $1,780 | $21 |
| Metoprolol | 48 | $1,573 | $33 |
| Levothyroxine | 52 | $1,491 | $29 |
| Warfarin | 110 | $1,399 | $13 |
| Lisinopril | 169 | $1,363 | $8 |
| Metformin | 170 | $905 | $5 |
| Hydrochlorothiazide | 185 | $890 | $5 |
| Pioglitazone | 33 | $861 | $26 |
| Enalapril Maleate | 21 | $832 | $40 |
| Amitriptyline | 50 | $740 | $15 |
| Primidone | 12 | $731 | $61 |
| Tamsulosin | 27 | $690 | $26 |
| Simvastatin | 114 | $671 | $6 |
| Glimepiride | 69 | $668 | $10 |
| Finasteride | 36 | $533 | $15 |
| Bd Ultra-Fine Pen Needle | 16 | $517 | $32 |
| Fluticasone Propionate | 35 | $513 | $15 |
| Ibuprofen | 56 | $501 | $9 |
| Losartan | 63 | $500 | $8 |
| Fluocinonide | 13 | $466 | $36 |
| Lovastatin | 35 | $439 | $13 |
| Furosemide | 88 | $434 | $5 |
| Oxycodone-Acetaminophen | 13 | $416 | $32 |
| Fluoxetine | 15 | $409 | $27 |
| Citalopram Hbr | 51 | $399 | $8 |
| Lactulose | 26 | $399 | $15 |
| Amlodipine Besylate | 81 | $381 | $5 |
| Acetaminophen-Codeine | 26 | $375 | $14 |
| Carvedilol | 47 | $349 | $7 |
| Alendronate | 39 | $322 | $8 |
| Amlodipine Besylate-Benazepril | 11 | $316 | $29 |
| Allopurinol | 17 | $266 | $16 |
| Clopidogrel | 19 | $265 | $14 |
| Ranitidine | 46 | $252 | $5 |
| Lisinopril-Hydrochlorothiazide | 25 | $250 | $10 |
| Temazepam | 12 | $203 | $17 |
| Sertraline | 29 | $198 | $7 |
| Benazepril | 24 | $178 | $7 |
| Triamterene-Hydrochlorothiazid | 23 | $171 | $7 |
| Polyethylene Glycol 3350 | 11 | $154 | $14 |
| Metoprolol | 32 | $149 | $5 |
| Pantoprazole | 13 | $133 | $10 |
| Paroxetine | 12 | $105 | $9 |
| Levetiracetam | 12 | $102 | $8 |
| Tramadol | 33 | $78 | $2 |
| Lorazepam | 14 | $75 | $5 |
| Cyclobenzaprine | 13 | $55 | $4 |
| Glipizide | 11 | $25 | $2 |
2014: 69 drugs
| Xifaxan | 14 | $18,674 | $1,334 |
| Spiriva | 30 | $16,513 | $550 |
| Advair Diskus | 21 | $13,334 | $635 |
| Crestor | 22 | $9,455 | $430 |
| Combivent Respimat | 23 | $9,190 | $400 |
| Flovent Hfa | 26 | $8,447 | $325 |
| Lantus Solostar | 26 | $7,999 | $308 |
| Hydrocodone-Acetaminophen | 144 | $7,902 | $55 |
| Benicar | 24 | $5,994 | $250 |
| Azilect | 11 | $5,371 | $488 |
| Proair Hfa | 47 | $4,746 | $101 |
| Tolterodine Tartrate Er | 11 | $3,487 | $317 |
| Symbicort | 11 | $2,809 | $255 |
| Vesicare | 12 | $2,562 | $214 |
| Omeprazole | 255 | $2,335 | $9 |
| Atorvastatin | 127 | $2,214 | $17 |
| Gabapentin | 86 | $2,043 | $24 |
| Metoprolol | 52 | $1,882 | $36 |
| Lisinopril | 200 | $1,825 | $9 |
| Doxazosin Mesylate | 56 | $1,774 | $32 |
| Fenofibrate | 26 | $1,688 | $65 |
| Ventolin Hfa | 16 | $1,454 | $91 |
| Levothyroxine | 58 | $1,426 | $25 |
| Hydrochlorothiazide | 177 | $1,200 | $7 |
| Metformin | 131 | $1,118 | $9 |
| Lactulose | 34 | $971 | $29 |
| Potassium Chloride | 30 | $914 | $30 |
| Simvastatin | 152 | $880 | $6 |
| Pioglitazone | 36 | $855 | $24 |
| Warfarin | 85 | $781 | $9 |
| Carvedilol | 68 | $722 | $11 |
| Glimepiride | 51 | $686 | $13 |
| Losartan | 58 | $625 | $11 |
| Finasteride | 33 | $581 | $18 |
| Fluticasone Propionate | 31 | $531 | $17 |
| Amlodipine Besylate | 72 | $510 | $7 |
| Diltiazem 24hr Er | 17 | $503 | $30 |
| Ibuprofen | 49 | $502 | $10 |
| Lovastatin | 44 | $467 | $11 |
| Primidone | 12 | $441 | $37 |
| Furosemide | 91 | $399 | $4 |
| Amitriptyline | 54 | $376 | $7 |
| Clopidogrel | 20 | $373 | $19 |
| Sertraline | 39 | $371 | $10 |
| Glyburide | 15 | $342 | $23 |
| Enalapril Maleate | 13 | $337 | $26 |
| Ranitidine | 39 | $313 | $8 |
| Amlodipine Besylate-Benazepril | 13 | $308 | $24 |
| Tramadol | 44 | $276 | $6 |
| Lisinopril-Hydrochlorothiazide | 31 | $274 | $9 |
| Tamsulosin | 16 | $267 | $17 |
| Alendronate | 21 | $255 | $12 |
| Spironolactone | 15 | $247 | $16 |
| Citalopram Hbr | 53 | $246 | $5 |
| Fluoxetine | 17 | $236 | $14 |
| Pantoprazole | 15 | $178 | $12 |
| Allopurinol | 14 | $164 | $12 |
| Triamterene-Hydrochlorothiazid | 15 | $161 | $11 |
| Benazepril | 16 | $149 | $9 |
| Temazepam | 18 | $143 | $8 |
| Prednisone | 14 | $127 | $9 |
| Acetaminophen-Codeine | 15 | $126 | $8 |
| Naproxen | 21 | $122 | $6 |
| Triamcinolone Acetonide | 15 | $110 | $7 |
| Glipizide | 14 | $97 | $7 |
| Hydroxyzine | 13 | $83 | $6 |
| Cyclobenzaprine | 19 | $70 | $4 |
| Atenolol | 14 | $57 | $4 |
| Trazodone | 13 | $53 | $4 |
2013: 87 drugs
| Spiriva | 44 | $19,419 | $441 |
| Advair Diskus | 38 | $19,084 | $502 |
| Xifaxan | 13 | $16,051 | $1,235 |
| Lantus Solostar | 31 | $8,917 | $288 |
| Crestor | 23 | $8,747 | $380 |
| Oxycontin | 11 | $6,859 | $624 |
| Benicar | 32 | $6,406 | $200 |
| Pradaxa | 23 | $6,003 | $261 |
| Combivent Respimat | 16 | $5,537 | $346 |
| Pioglitazone | 39 | $5,372 | $138 |
| Hydrocodone-Acetaminophen | 193 | $5,178 | $27 |
| Flovent Hfa | 17 | $4,928 | $290 |
| Pioglitazone-Metformin | 13 | $4,295 | $330 |
| Detrol La | 14 | $4,277 | $306 |
| Proair Hfa | 42 | $3,953 | $94 |
| Lantus | 20 | $3,598 | $180 |
| Metoprolol | 77 | $3,073 | $40 |
| Symbicort | 12 | $2,899 | $242 |
| Omeprazole | 227 | $2,821 | $12 |
| Gabapentin | 79 | $2,682 | $34 |
| Atorvastatin | 105 | $2,581 | $25 |
| Fenofibrate | 40 | $2,558 | $64 |
| Lyrica | 11 | $2,536 | $231 |
| Ventolin Hfa | 28 | $2,328 | $83 |
| Humalog | 11 | $2,248 | $204 |
| Vesicare | 11 | $2,229 | $203 |
| Novolin 70-30 | 15 | $2,216 | $148 |
| Lisinopril | 259 | $2,159 | $8 |
| Felodipine Er | 31 | $1,743 | $56 |
| Simvastatin | 220 | $1,624 | $7 |
| Metformin | 135 | $1,185 | $9 |
| Lactulose | 31 | $1,143 | $37 |
| Azelastine | 12 | $1,081 | $90 |
| Hydrochlorothiazide | 181 | $1,060 | $6 |
| Levothyroxine | 90 | $991 | $11 |
| Isosorbide Dinitrate | 11 | $956 | $87 |
| Finasteride | 42 | $920 | $22 |
| Fluticasone Propionate | 46 | $905 | $20 |
| Warfarin | 91 | $856 | $9 |
| Doxazosin Mesylate | 50 | $856 | $17 |
| Losartan | 54 | $809 | $15 |
| Fluoxetine | 20 | $742 | $37 |
| Diltiazem 24hr Er | 24 | $698 | $29 |
| Ranitidine | 57 | $687 | $12 |
| Amlodipine Besylate | 79 | $607 | $8 |
| Lovastatin | 46 | $606 | $13 |
| Glyburide | 20 | $544 | $27 |
| Bd Ultra-Fine Pen Needle | 13 | $539 | $41 |
| Montelukast | 17 | $523 | $31 |
| Carvedilol | 62 | $515 | $8 |
| Furosemide | 114 | $511 | $4 |
| Clopidogrel | 25 | $486 | $19 |
| Glimepiride | 87 | $486 | $6 |
| Bupropion Hcl Sr | 11 | $468 | $43 |
| Primidone | 12 | $394 | $33 |
| Phenytoin Sodium Extended | 13 | $381 | $29 |
| Amitriptyline | 78 | $343 | $4 |
| Sertraline | 28 | $325 | $12 |
| Insulin | 12 | $323 | $27 |
| Spironolactone | 19 | $312 | $16 |
| Metoprolol | 31 | $307 | $10 |
| Acetaminophen-Codeine | 25 | $304 | $12 |
| Citalopram Hbr | 53 | $296 | $6 |
| Potassium Chloride | 16 | $283 | $18 |
| Ibuprofen | 38 | $275 | $7 |
| Tamsulosin | 15 | $265 | $18 |
| Lisinopril-Hydrochlorothiazide | 22 | $258 | $12 |
| Alendronate | 29 | $228 | $8 |
| Triamcinolone Acetonide | 22 | $226 | $10 |
| Polyethylene Glycol 3350 | 12 | $220 | $18 |
| Allopurinol | 13 | $205 | $16 |
| Ramipril | 15 | $175 | $12 |
| Naproxen | 21 | $171 | $8 |
| Tramadol | 25 | $154 | $6 |
| Glipizide | 29 | $139 | $5 |
| Clonidine | 19 | $137 | $7 |
| Benazepril | 12 | $130 | $11 |
| Temazepam | 17 | $113 | $7 |
| Atenolol | 36 | $106 | $3 |
| Hydroxyzine | 13 | $93 | $7 |
| Prednisone | 19 | $89 | $5 |
| Zolpidem | 15 | $82 | $5 |
| Baclofen | 15 | $81 | $5 |
| Triamterene-Hctz | 14 | $73 | $5 |
| Trazodone | 15 | $71 | $5 |
| Propranolol | 15 | $64 | $4 |
| Lorazepam | 13 | $52 | $4 |
Money from drug and device companies
$37 in 2024
| 2024 | 2 | 2 | None | $37 |
| 2023 | 6 | 8 | None | $150 |
| 2022 | 5 | 7 | None | $114 |
| 2021 | 5 | 9 | None | $140 |
| 2020 | 2 | 2 | None | $30 |
| 2019 | 3 | 4 | None | $58 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Salix Pharmaceuticals a division of Bausch Health US | Xifaxan | $20 | 1 payment
|
| Novo Nordisk | Rybelsus | $17 | 1 payment
|
See all 2 published payments
| Novo Nordisk | Meals · 2024-05-21 | Rybelsus | $17 |
| Salix Pharmaceuticals a division of Bausch Health US | Meals · 2024-03-20 | Xifaxan | $20 |
See earlier years (2023, 2022, 2021, 2020, 2019)
2023: $150
| Merck Sharp & Dohme | Pifeltro | $48 | 3 payments
|
| ViiV Healthcare | Apretude | $24 | 1 payment
|
| Salix Pharmaceuticals a division of Bausch Health US | Xifaxan | $22 | 1 payment
|
| Sanofi Pasteur | Fluzone Quadrivalent Northern Hemisphere | $20 | 1 payment
|
| Gilead Sciences | None | $19 | 1 payment
|
| Xeris Pharmaceuticals | Gvoke Hypopen | $16 | 1 payment
|
2022: $114
| Novo Nordisk | Ozempic | $31 | 2 payments
|
| Merck Sharp & Dohme | Gardasil 9 | $25 | 2 payments
|
| ViiV Healthcare | Cabenuva | $23 | 1 payment
|
| Gilead Sciences | None | $22 | 1 payment
|
| Janssen Pharmaceuticals | Invega Sustenna | $13 | 1 payment
|
2021: $140
| Merck Sharp & Dohme | Januvia | $44 | 3 payments
|
| ViiV Healthcare | Cabenuva | $36 | 2 payments
|
| Novo Nordisk | Rybelsus | $30 | 2 payments
|
| Janssen Pharmaceuticals | Xarelto | $16 | 1 payment
|
| Cranial Technologies | Doc Band | $15 | 1 payment
|
2020: $30
| ViiV Healthcare | Dovato | $17 | 1 payment
|
| Janssen Pharmaceuticals | Spravato | $13 | 1 payment
|
2019: $58
| Novo Nordisk | Tresiba | $32 | 2 payments
|
| Otsuka America Pharmaceutical | Abilify Maintena | $15 | 1 payment
|
| Merck Sharp & Dohme | Januvia | $11 | 1 payment
|
Professional record
- NPI
- 1922187574
- Licence
- CA A76677California A76677: Current · expires 2027-08-31
- Trained
- New York Medical College, 2000 · 26 years ago
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Family medicine (207Q00000X)
- Mailing address
- P.O. Box 1260, Davis, CA, 95616
- NPI first listed
- 2006-11-03
- NPI last updated
- 2025-04-21
- NPI record certified
- 2025-04-21
This is when the NPI record was last certified, not a medical board exam.